home All News open_in_new Full Article

NetraMark’s AI Significantly Outperforms ChatGPT, DeepSeek and Traditional Machine Learning in Clinical Trial Subpopulation Discovery, Offers New Path for Trial Success

TORONTO, June 23, 2025 (GLOBE NEWSWIRE) — NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming clinical trials has released a new preprint on arXiv demonstrating that its flagship AI platform, NetraAI, has substantially outperformed leading large language models, DeepSeek and ChatGPT. […]


today 1 week ago attach_file Technology

attach_file Economics
attach_file Events
attach_file Transport
attach_file Other
attach_file Sport
attach_file Other
attach_file Society
attach_file Politics
attach_file Politics
attach_file Events
attach_file Other
attach_file Science
attach_file Economics
attach_file Economics
attach_file Culture
attach_file Culture
attach_file Events
attach_file Politics
attach_file Politics
attach_file Transport


ID: 3431039195
Add Watch Country

arrow_drop_down